Navigation Links
Myriad Genetics Presents Mathematical Comparison of Disease,Modification Trial Designs at Alzheimer's ConferenceCurrent,Flurizan Phase 3 Study Design May Demonstrate Disease Modification

ion label for Flurizan."

About Flurizan(TM)

Myriad has two Phase 3 trials of Flurizan ongoing in patients with mild Alzheimer's disease. In each study, participants are taking 800 mg of Flurizan or placebo twice daily, and participants enrolled will have taken the study drug for 18 months. Flurizan is the first in a new class of drug candidates known as Selective Amyloid beta-42 Lowering Agents (SALAs). Flurizan lowered levels of Abeta42 in cellular assays and animal models. Abeta42 is the primary constituent of senile plaque that accumulates in the brain of patients with Alzheimer's disease. It is thought to be the key initiator of Alzheimer's disease, since Abeta42 has the greatest tendency to aggregate, cause neuronal damage and initiate amyloid deposits in the brain. Most genetic mutations that cause early-onset Alzheimer's disease appear to do so by increasing production of Abeta42. Myriad believes that Flurizan is the most advanced drug candidate that modifies the production of Abeta42 to be evaluated in a clinical trial for the treatment of Alzheimer's disease.

About Myriad

Myriad Genetics, Inc. is a biopharmaceutical company focused on the development and marketing of novel healthcare products. The Company develops and markets molecular diagnostic products, and is developing and intends to market therapeutic products. Myriad's news and other information are available on the Company's Web site at www.myriad.com. Flurizan is a trademark of Myriad Genetics, Inc. in the United States and other countries.

This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include whether the Flurizan Phase 3 study design may demonstrate disease modification; the Company's use of the Natural History Staggered Start trial design and trial analysis methodology in its Flurizan Phase
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Myriad Genetics Presents Tumor Origin Technology at AACR
2. Myriad Genetics Presents Azixas Mode of Action at AACR
3. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
4. Genetics Journal Thimerosal/Autism Study the Best Science Drug Company Money Can Buy
5. Targeted Genetics Reports Inflammatory Arthritis Clinical Data at European Rheumatology Conference
6. ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial in B-Cell Chronic Lymphocytic Leukemia
7. Seattle Genetics Highlights Data on its Proprietary Antibody-Drug Conjugate Technology at AACR
8. Aeolus Pharmaceuticals AEOL 10150 Highlighted in Nature Genetics Publication
9. Expression Genetics, Inc. Announces Successful Completion of Phase I Trial of Gene-Based IL-12 for Treatment of Ovarian Cancer
10. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
11. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference

Post Your Comments:
(Date:11/29/2009).../ -- Royal Philips Electronics ( PHG, AEX: PHI) to...showing its portfolio of products designed to mana...ng of the Radiological Society of North America (R...everal advancements and upgrades focused on redefi...ning workflow to expand upon clinical capabilities...
(Date:11/29/2009)... -- FUJIFILM Medical Systems USA, Inc., the world ...th over 7,000 installations, is pleased to debut t...e US. The Aspire HD combines the use of advanced ...on detector technology and the smallest pixel size...ion at a reduced dose for the patient. The flexib...
(Date:11/29/2009)... Researchers using functional magnetic resonance i... that men and women respond differently to positiv...nted today at the annual meeting of the Radiologic... direct more attention to sensory aspects of emoti...implications for required action, whereas women di...
Breaking Medicine Technology:Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 2Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 3Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 4Philips Responds to Industry Concerns With Focus on Radiation Dose Management Products Designed for Clinicians and Patients 5FUJIFILM's DR-based FFDM System Makes US Debut at RSNA 2FUJIFILM's DR-based FFDM System Makes US Debut at RSNA 3FUJIFILM's DR-based FFDM System Makes US Debut at RSNA 4New Study Finds Men and Women May Respond Differently to Danger 2New Study Finds Men and Women May Respond Differently to Danger 3Volcano Corporation and Siemens Healthcare Announce Global Resale Agreement for Volcano IVUS FFR Systems 55259 1Volcano Corporation and Siemens Healthcare Announce Global Resale Agreement for Volcano IVUS FFR Systems 55259 2Volcano Corporation and Siemens Healthcare Announce Global Resale Agreement for Volcano IVUS FFR Systems 55259 3Volcano Corporation and Siemens Healthcare Announce Global Resale Agreement for Volcano IVUS FFR Systems 55259 4Nick Jonas 3A Livin the Dream Despite Diabetes 55255 1Nick Jonas 3A Livin the Dream Despite Diabetes 55255 2Nick Jonas 3A Livin the Dream Despite Diabetes 55255 3Nick Jonas 3A Livin the Dream Despite Diabetes 55255 4Naked 28R 29 Juice Brings Power to the People With Two New Protein Zone Flavors 3A Mango and Double Berry 55251 1Naked 28R 29 Juice Brings Power to the People With Two New Protein Zone Flavors 3A Mango and Double Berry 55251 2
...intained Long-term Response at Stable Doses, Accor...ek (DDW), ATLANTA, May 22, 2007 /PRNewswire/ -- UC...tive Disease Week 2007 (DDW),demonstrated long-ter...ts treated with Cimzia (certolizumab pegol), the o...he study, called PRECiSE 3 (P3), is a long-term op...
...ay 22, 2007 /PRNewswire-FirstCall/ -- Sosei Group,...nnounces the,successful completion of a study of i...nalgesic for the treatment of cancer,breakthrough ...centre, open-label,single dose, cross-over, rando...ucosal fentanyl citrate lozenge) and versus fentan...
Other Medicine Technology:UCB Presents Long-Term CImzia Data in Crohn's Disease 2UCB Presents Long-Term CImzia Data in Crohn's Disease 3UCB Presents Long-Term CImzia Data in Crohn's Disease 4UCB Presents Long-Term CImzia Data in Crohn's Disease 5Sosei Announces Successful Completion of AD 923 Pharmacokinetic,Study in the USA 2Sosei Announces Successful Completion of AD 923 Pharmacokinetic,Study in the USA 3
(Date:11/27/2009)...ass., Nov. 27 GSI Group ...er of precision technology products and semiconduc...g of the Company,s shareholders has been scheduled...n of the meeting will be announced in due course. ...equisition notice from Stephen Bershad, a holder o...
(Date:11/27/2009)...N.Y., Nov. 27 Preventin...r and fortunately every year, new vaccines are bei...ll vaccines boost immunity for the same period of ...ots, needed to keep immunity strong? ,, In th... American Academy of Pediatrics, Michael Pichicher...
(Date:11/27/2009)...unprecedented medical, economic burdens, study pre...s) -- The number of people with diabetes in the Un... years, a new study predicts. , That would brin...ith the disease, up from 23.7 million today. , ,...h diabetes will triple, the study also warns, risi...
(Date:11/27/2009)... Three new interactive anatomy education apps fr...expand health sciences learning opportunities for ...urham, NC (Vocus) November 27, 2009 -- Modality, ... a division of Wolters Kluwer Health, today announ...n apps on the App Store. Clemente’s Anatomy,...
(Date:11/26/2009)...or too heavy can lead to strains or worse , ...may be nothing wrong with stuffing your turkey ful...me thing with your suitcase as you pack for holida... in 2008 in U.S. hospital emergency rooms, doctors...r luggage-related injuries, such as muscle strains...
Breaking Medicine News(10 mins):Health News:GSI Group Calls Shareholders Meeting 2Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Pack Right for the Holidays to Avoid the ER 2
... studies, reveals depression medications containin...rmonal levels causing a decrease in libido. , ...31, 2008 -- Recent trends of antidepressants being...ome the most commonly prescribed drug in the Unite...
...onda is hosting a blood drive at its Phillipsburg ...:45PM. , Phillipsburg, NJ...a is hosting a blood drive at its Phillipsburg loc...ides this life-saving commodity to over seventeen ...
...n nature and regenerates damaged skin tissues give...in repair itself from within. , ...nsitive, troubled and photo-damaged skin can be a ...hese ailments can be hard to heal on their own, le...
...CEP (E), Executive Director, American Public Hea...n Public,Health Association applauds the U.S. Hous...Smoking and Tobacco Control Act with an overwhelmi...A) the authority to regulate tobacco products., F...
...atives today took a historic step to save lives by... Drug Administration (FDA),authority over tobacco ...,tobacco marketing and sales to kids. The bill pas...voted for the bill,last August as a member of the ...
...latory authority over,tobacco products, WASHINGTO... Heyman, M.D., Board Chair, American Medical,Assoc...s took a critical step to,combat smoking-related d...of the U.S. Senate will truly consider the,countle...
Other Medicine News:Health News:Lyriana Announces Antidepressants Now Linked to Declining Libido in Women 2Health News:Lyriana Announces Antidepressants Now Linked to Declining Libido in Women 3Health News:Lyriana Announces Antidepressants Now Linked to Declining Libido in Women 4Health News:Phillipsburg Easton Honda to Host Miller-Keystone Blood Drive 2Health News:Phillipsburg Easton Honda to Host Miller-Keystone Blood Drive 3Health News:New Skin Revitalizing Product Uses Naturally Occurring Serum for the Repair of Sun Damaged Skin 2Health News:New Skin Revitalizing Product Uses Naturally Occurring Serum for the Repair of Sun Damaged Skin 3Health News:House Passes Historic Bill to Protect Kids From Tobacco; Senator Voinovich Should Cosponsor Legislation 2
DLP® Elongated One-Piece Pediatric Arterial Cannulae (EOPA)
Select Series® Straight Tip and Angled Tip Arterial Cannulae
Intermittent Catheters - Female
Intermittent Catheters - Long/Adolescent
Medicine Products: